NIH-funded research R21 grant

Improving lung preservation for transplantation using liver cell function

Official title: Incorporating hepatic cell function into lung ex vivo lung perfusion for transplant preservatio

Funded at University of Chicago · NIH-11099018 · Data updated 2026-11-12

This study is exploring a new way to keep donated lungs in better shape for transplant by using liver cells during the preservation process, which could help improve the success of lung transplants for patients.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startMay 31, 2024
Project endJanuary 31, 2026
Funding year2024
Award (this year)$167,908
NIH project number7R21HL164436-03
Project IDNIH-11099018 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals awaiting lung transplantation who may benefit from improved preservation techniques.

Less likely to help

Patients who are not candidates for lung transplantation or those with conditions that preclude them from receiving a transplant may not benefit from this research.

What this research studies

This research investigates a new method to enhance the preservation of lung grafts for transplantation by incorporating liver cell function into the ex vivo lung perfusion process. The approach aims to maintain normothermic circulation and ventilation, which could improve lung quality during preservation. By utilizing liver cell bioreactors, the study seeks to mitigate the toxic effects of prolonged lung preservation and reduce the risk of primary graft dysfunction. This innovative method could lead to better outcomes for patients receiving lung transplants.

Why it matters

Potential benefit: If successful, this research could significantly improve lung transplant outcomes and increase the survival rates of patients post-transplant.

How similar studies have gone: Previous studies have shown promise in using cross-circulation models to enhance lung resuscitation, indicating that this approach may lead to significant advancements in lung preservation.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Sanchez, Pablo G — University of Chicago
  • Study coordinator: Sanchez, Pablo G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.